Horizon Pharma plc has abandoned its hostile pursuit of Depomed Inc. after a judge in California came down against the Ireland-based bidder both on its argument that a poison pill adopted by Depomed might be unlawful, and on Depomed's motion for an injunction against Horizon's offer for its alleged use of confidential information.
Horizon said it strongly disagreed with the court's ruling but was anyway withdrawing its offer for Depomed. Chairman, president and...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
